Gut metabolites identified in cerebrospinal fluid of genetic interferonopathy support gut–brain endothelial dysfunction

Documenti analoghi

• cGAS inhibitor IMSB301 modifies interferon signalling in peripheral mononuclear cells of SAMHD1 genetic interferonopathy in vitro
  di: Velda X Han, et al.
  Pubblicazione: (2026)
• The significance of Syndecan 1, a new marker for endothelial dysfunction, in cases of fetal growth retardation
  di: Yüksel Oğuz, et al.
  Pubblicazione: (2024)
• Causal relationship between immune cells, metabolites and polycystic ovary syndrome identified by Mendelian randomization and mediation analyses
  di: Lan Li, et al.
  Pubblicazione: (2025)
• Whole transcriptome profiling of placental pathobiology in SARS‐CoV‐2 pregnancies identifies placental dysfunction signatures
  di: Nataly Stylianou, et al.
  Pubblicazione: (2024)
• Exploring the Gut Ecosystem: Mechanism Studies From the Gut Microbiota to Inflammatory Cytokines to Inflammatory Bowel Disease
  di: Binbin Tang, et al.
  Pubblicazione: (2026)